LINC01629

Across TCGA pan-cancer cohorts, LINC01629 RNA differs between tumor and matched normal tissue in 10 of 18 cancer types tested, making tumor–normal expression one of LINC01629’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where LINC01629 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC01629 is over-expressed in tumor, although a few such as KIRC and COAD show the opposite, repressed pattern.

KIRC, LUAD, and HNSC are the cancer types where LINC01629 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01629 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	II,III,IV	−0.471	<.001	11	view →
LUAD	All	II,III,IV	+0.845	<.001	9	view →
HNSC	All	All	+0.858	<.001	7	view →
THCA	Male	All	+1.187	<.001	6	view →
COAD	All	All	−0.187	.009	6	view →
LUSC	All	All	+0.946	<.001	5	view →
BRCA	Female	All	−0.352	<.001	4	view →
KICH	All	All	−0.746	.025	2	view →
PRAD	All	All	−0.522	<.001	2	view →
LIHC	Female	All	+0.025	.036	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 10 strongest of 10 lineages.

LINC01629–KIRC

Open the KIRC breakdown →